Amla tablets
Emblica officinalis (amla) 250mg
Approved
Registration Information
- Food ID
- 6620
- Status
- Approved
- Application Type
- Generic/Biosimilars
- Classification
- Human
Product Information
- Active Ingredient
- Emblica officinalis (amla) 250mg
- Strength
- Emblica officinalis (amla) 250mg
- Dosage Form
- Tablet
- Route of Administration
- Oral
- Packaging
- 30
- Visual Description
- Light to dark brown coloured film coated tablets
- Shelf Life
- N/A
Manufacturer Information
- Manufacturer / Site
- Biolife Technologies
- MAH (Marketing Authorization Holder)
- Jasspin Kenya Ltd
- Country
- India
- Local / Foreign
- Foreign
Record Information
- Last Fetched
- 2026-02-28 02:56:16
- Last Updated
- 2026-09-23 02:56:21
Important Notice
This information is sourced from the Pharmacy and Poisons Board of Kenya. Always consult with a qualified healthcare professional before using any supplement.